Skip to main content
HR 1988 112th Congress House Taxation Business investment and capital Drug therapy Health technology, devices, supplies Income tax credits Medical research Medical tests and diagnostic methods

Qualifying Therapeutic Discovery Project Tax Credit Extension Act of 2011

Introduced: May 25, 2011 See on congress.gov
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 3, 2011
Referred to the Subcommittee on Health.
May 25, 2011
Referred to the Committee on Ways and Means, and in addition to the Committees on Appropriations, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 25, 2011
Introduced in House
 Plain-English summary Congressional Research Service

Qualifying Therapeutic Discovery Project Tax Credit Extension Act of 2011 - Amends the Internal Revenue Code to extend for an additional five-year period the authority to invest in and allocate credit amounts for a qualifying therapeutic discovery project (a project that is designed to: (1) treat or prevent diseases by conducting pre-clinical activities, clinical trials, and clinical studies, or by carrying out research projects to approve new drugs or other biologic products; (2) diagnose diseases or conditions to determine molecular factors related to diseases or conditions; or (3) develop a product, process, or technology to further the delivery or administration of therapeutics).

Extends for an additional five-year period the authority of the Secretary of the Treasury to award grants for investment in a qualifying therapeutic discovery project in lieu of a tax credit and the funding for such grants.

What's happening now June 3, 2011

Referred to the Subcommittee on Health.

 Committees of jurisdiction 4